Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Kroll

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 25, 2012
Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compoundsAimo Kannt, Kerstin Sicka, Katja Kroll, et al.
Preparative Biochemistry & Biotechnology|September 1, 2017
Expression and purification of the extracellular domains of human glycoprotein VI (GPVI) and the receptor for advanced glycation end products (RAGE) from Rattus norvegicus in Leishmania tarentolaeThomas Langer, Carsten Corvey, Katja Kroll, et al.
Biochemical and Biophysical Research Communications|February 18, 2014
Crystal structure of cathepsin A, a novel target for the treatment of cardiovascular diseasesHerman A Schreuder, Alexander Liesum, Katja Kroll, et al.
Journal of Medicinal Chemistry|August 7, 2012
Novel β-amino acid derivatives as inhibitors of cathepsin ASven Ruf, Christian Buning, Herman Schreuder, et al.
Mabs|August 12, 2021
An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeuticsNorbert Furtmann, Marion Schneider, Nadja Spindler, et al.
Analytical Chemistry|June 27, 2023
High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass SpectrometryTanja Ziegengeist, Jennifer Orth, Katja Kroll, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 25, 2012
Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compoundsAimo Kannt, Kerstin Sicka, Katja Kroll, et al.
Preparative Biochemistry & Biotechnology|September 1, 2017
Expression and purification of the extracellular domains of human glycoprotein VI (GPVI) and the receptor for advanced glycation end products (RAGE) from Rattus norvegicus in Leishmania tarentolaeThomas Langer, Carsten Corvey, Katja Kroll, et al.
Biochemical and Biophysical Research Communications|February 18, 2014
Crystal structure of cathepsin A, a novel target for the treatment of cardiovascular diseasesHerman A Schreuder, Alexander Liesum, Katja Kroll, et al.
Journal of Medicinal Chemistry|August 7, 2012
Novel β-amino acid derivatives as inhibitors of cathepsin ASven Ruf, Christian Buning, Herman Schreuder, et al.
Mabs|August 12, 2021
An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeuticsNorbert Furtmann, Marion Schneider, Nadja Spindler, et al.
Analytical Chemistry|June 27, 2023
High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass SpectrometryTanja Ziegengeist, Jennifer Orth, Katja Kroll, et al.
Pageof 1